Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Digitalis in the elderly.

M Chellingsworth

    Journal of Clinical and Hospital Pharmacy
    |February 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Digitalis preparations are commonly used in elderly patients, but their effectiveness is debated due to potential toxicity and the availability of newer treatments for heart conditions.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Use of interferon beta 1b for multiple sclerosis. Patients will put up with side effects because of their desire to beat the disease.

    BMJ (Clinical research ed.)·1996
    Same author

    Prevention and management of steroid-induced osteoporosis.

    British journal of hospital medicine·1994
    Same author

    The destination and dependency of patients discharged from care of the elderly units in the West Midlands.

    Health trends·1989
    Same author

    Calcium antagonists and the kidney.

    Journal of human hypertension·1987
    Same author

    The treatment of hypertension in the elderly.

    Postgraduate medical journal·1986
    Same author

    Progressive systemic sclerosis, immunosuppression and necrotising arteritis: cause or effect?

    Clinical rheumatology·1985
    Same journal

    Chemical stabilities of lignocaine hydrochloride and phenylephrine hydrochloride in aqueous solution.

    Journal of clinical and hospital pharmacy·1986
    Same journal

    A comparison of graphical nomogram methods with a computerized Bayesian analysis method in the interpretation of serum phenytoin concentrations.

    Journal of clinical and hospital pharmacy·1986
    Same journal

    Therapeutic progress--review XXIII. Are we making progress in the treatment of acute stroke?

    Journal of clinical and hospital pharmacy·1986
    Same journal

    Therapeutic progress--review XXIII. Morphine analgesia in terminal care.

    Journal of clinical and hospital pharmacy·1986
    Same journal

    The therapy of genital warts.

    Journal of clinical and hospital pharmacy·1986
    Same journal

    Recent advances in pharmaceutical chemistry--review II. Histamine H2-receptor antagonists.

    Journal of clinical and hospital pharmacy·1986
    See all related articles

    Area of Science:

    • Cardiology
    • Geriatrics
    • Pharmacology

    Background:

    • Digitalis has a long history, first described by William Withering over 200 years ago.
    • Digitalis preparations are frequently prescribed for elderly patients.
    • Studies indicate a high prevalence of digitalis use and toxicity in hospital in-patients.

    Purpose of the Study:

    • To review the current value of cardiac glycosides in treating elderly patients.
    • To address the controversy surrounding digitalis use in geriatric populations.

    Main Methods:

    • Literature review of studies on digitalis use and toxicity in the elderly.
    • Analysis of survey data on digitalis prescription rates in different age groups.

    Main Results:

    Related Experiment Videos

    • Surveys show a significant percentage of elderly individuals use digitalis preparations.
    • While digitalis use is common, its toxicity is also noted, though not consistently linked to age.
    • Newer, effective treatments for heart failure and atrial arrhythmias are now available.

    Conclusions:

    • The established role of cardiac glycosides in elderly care is being questioned.
    • The advent of advanced diuretics, vasodilators, and antiarrhythmics challenges the continued widespread use of digitalis.
    • Further evaluation is needed to determine the optimal place for digitalis in modern geriatric cardiology.